Open AccessDisease Severity Caused by Microbial Infections and Biology of COVID-19 & Omnicron Viruses and Management through Drug's
Author(s) -
Bakhtawar Maqbool,
Aamal Haleem,
Muhammad Iqbal,
Muzammil Ali,
Bisma Arshad,
Asif Ali,
Qasim Qasim,
Javed Javed,
Qamar Iqbal
Publication year - 2022
Publication title -
saudi journal of medical and pharmaceutical sciences
Language(s) - English
Resource type - Journals
eISSN - 2413-4929
pISSN - 2413-4910
DOI - 10.36348/sjmps.2022.v08i02.006
Subject(s) - virus , infectious disease (medical specialty) , disease , biology , drug , virology , immune system , covid-19 , antibody , immunology , medicine , pharmacology , pathology
Viruses are the group of infectious particles and some of them possess the more complex structures due to which their growth proliferated at the extreme level as compared to the bacterial infections. Pharmacokinetics of some drugs needed to further more in order to explore them in the medical events or sometimes drug research increase the chances of treatment of infectious disease during the course of replicating cycle. Among them, coronaviruses are appearing on different form of variants. These are Beta, Delta, and Omicron variants and each type have different sequence of the amino acids. Due to colonization of the virus particles in the particular tissues, many of the immune cells show response against variety of viral proteins. Severity of viruses attack to the cardiovascular systems causing the borne of different cardiovascular diseases. Different traditional methods for molecular diagnosis of infectious particles but not reliable, but through molecular sequencing of certain mutation associated with lungs tissues may evoke the viral spikes proteins. Due to severe attack on the lung tissues, blood rushes and flow increases in the form of infectious particles. Vaccinations and antibodies are used for control their growth but some of the necessary measures in order to control the viral infections.